IDO2 — MultiTargetDB

Summary

KEGG Pathways (4)

Top Co-occurrence Targets

InChIKey	pChEMBL	Type	Targets	Clinical
`BKUGUNMYPVWLQG`	7.7	IC50	2	—
`BMRIDLQOFFJMOB`	7.7	IC50	2	—
`DXBKRSLPUQZYKO`	7.7	IC50	2	—
`FTQDDOKIOPOULH`	7.7	IC50	2	—
`GEXOCTLBVBEGMC`	7.7	IC50	2	—
`HLDAASUGYXJYNJ`	7.7	IC50	2	—
`IVBVHZLBOSJDGL`	7.7	IC50	2	—
`JTJCEQZOVLDYQU`	7.7	IC50	2	—
`LTJIQMPYPVYTNN`	7.7	IC50	2	—
`MHSMIKOMBZQUOP`	7.7	IC50	2	—
`NTSZIYCRLOTKQD`	7.7	IC50	2	—
`PPKJSBFMBJXWJY`	7.7	IC50	2	—
`QAXLWXFNLUATFQ`	7.7	IC50	2	—
`RBZNEFAEXSKEPD`	7.7	IC50	2	—
`RFUCCKCPSIAXAZ`	7.7	IC50	2	—
`VOQHCTXOBRTXNS`	7.7	IC50	2	—
`WFWZXACIKAFIEW`	7.7	IC50	2	—
`XLPVQJPRKKOSEL`	7.7	IC50	2	—
`ZQQNLFRCHWZMEJ`	7.7	IC50	2	—
`ZRTFRFAVOAUUTR`	7.7	IC50	2	—
`BDPOBDKNZXORIK`	7.2	IC50	2	—
`JPELNKFCFNAMEK`	7.2	IC50	2	—
`JZHOKQCKZGKMTP`	7.2	IC50	2	—
`OVQJJDXSCUWPCR`	7.2	IC50	2	—
`PTQDPGLSUJMCLM`	7.2	IC50	2	—
`KIIAYIPXLMATRX`	7.0	IC50	2	—
`IZIPUBCVABNVBJ`	6.9	IC50	2	—
`LFOXSTPPEXOYIT`	6.8	IC50	2	—
`JMUQGCMUIAFBTI`	6.5	IC50	2	—
`PNWWIOCNZXFHEC`	6.5	IC50	2	—
`HCRPFHXLEWDMOC`	6.4	IC50	2	—
`LYWVCSBAIAWGOG`	6.4	IC50	2	—
`ZRFDBYNFXGNBLV`	6.3	IC50	2	—
`VKHVYEKNAOYHSG`	6.2	IC50	2	—
`VPZIQYMEUIFNFK`	6.2	IC50	2	—
`UFMQJYHLIUACCG`	6.2	IC50	3	—
`NKSRXNGZOJBLIW`	6.2	IC50	2	—
`FBKMWOJEPMPVTQ`	6.2	IC50	3	—
`FTIIEJSEIOPKGL`	6.1	IC50	2	—
`QAIZRHXQMNGPHM`	6.1	IC50	2	—
`MFTFSIBMQZESTC`	6.1	IC50	2	—
`WCQVJFBGCFNOBE`	6.1	IC50	2	—
`FCFOHWOBWFTUGD`	6.0	IC50	2	—
`FERWLPKYXZHRKQ`	6.0	IC50	2	—
`XUKYDBZWZFCDMX`	6.0	IC50	2	—
`ZFAPGVNYXOYHCU`	6.0	IC50	2	—